Skip to content
Open in App
Marelius logo

Marelius

web2

Marelius is a publicly traded US life-sciences company whose UK subsidiary provides regulatory,...

Symbol ยท MBPG
Company profile

About

Marelius is a publicly traded US life-sciences company whose UK subsidiary provides regulatory, clinical and training support to pharmaceutical and biotechnology programmes. Its wholly owned subsidiary, Marelius Biopharma Group Ltd, offers virtual and in-person instruction, regulatory strategy, clinical-development support and cross-border execution in regulated markets. The service portfolio also includes small-scale contract-manufacturing support, good manufacturing practice compliance and advisory for cell and gene therapy and central nervous system projects. Its regulatory work spans pathways administered by the US Food and Drug Administration, European Medicines Agency and UK Medicines and Healthcare products Regulatory Agency. Marelius Inc. changed its name from Argentum 47 Inc. in November 2025 and trades on OTCID under MBPG.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeOTC MarketsPrimary symbol: MBPG
Expert coverage

Marelius profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment